126 related articles for article (PubMed ID: 1761362)
1. Effect of sizofiran, a polysaccharide, on interferon gamma, antibody production and lymphocyte proliferation specific for hepatitis B virus antigen in patients with chronic hepatitis B.
Kakumu S; Ishikawa T; Wakita T; Yoshioka K; Ito Y; Shinagawa T
Int J Immunopharmacol; 1991; 13(7):969-75. PubMed ID: 1761362
[TBL] [Abstract][Full Text] [Related]
2. Effects of TJ-9 Sho-saiko-to (kampo medicine) on interferon gamma and antibody production specific for hepatitis B virus antigen in patients with type B chronic hepatitis.
Kakumu S; Yoshioka K; Wakita T; Ishikawa T
Int J Immunopharmacol; 1991; 13(2-3):141-6. PubMed ID: 1906436
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B core antigen-specific IFN-gamma production of peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection.
Inoue M; Kakumu S; Yoshioka K; Tsutsumi Y; Wakita T; Arao M
J Immunol; 1989 Jun; 142(11):4006-11. PubMed ID: 2469730
[TBL] [Abstract][Full Text] [Related]
4. In vitro production of antibody to hepatitis B core and E antigens by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection.
Tsutsumi Y; Kakumu S; Wakita T; Yoshioka K; Ishikawa T
J Immunol; 1990 Mar; 144(6):2389-93. PubMed ID: 2313098
[TBL] [Abstract][Full Text] [Related]
5. Effects of interferon-alpha treatment on hepatitis B virus antigen-specific immunologic responses in patients with chronic hepatitis B.
Ishikawa T; Kakumu S; Yoshioka K; Kurokawa S; Kusakabe A; Tahara H; Hirofuji H; Kawabe M
Liver; 1993 Apr; 13(2):95-101. PubMed ID: 8510492
[TBL] [Abstract][Full Text] [Related]
6. Mixed cryoglobulinemia type II in chronic hepatitis B associated with HBe-minus HBV mutant: cellular immune reactions and response to interferon treatment.
Löhr H; Goergen B; Weber W; Gödderz W; Meyer zum Büschenfelde KH; Gerken G
J Med Virol; 1994 Dec; 44(4):330-5. PubMed ID: 7897364
[TBL] [Abstract][Full Text] [Related]
7. Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B.
Hayashi PH; Beames MP; Kuhns MC; Hoofnagle JH; Di Bisceglie AM
Am J Gastroenterol; 1996 Nov; 91(11):2323-8. PubMed ID: 8931411
[TBL] [Abstract][Full Text] [Related]
8. The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype.
Milich DR; Schödel F; Hughes JL; Jones JE; Peterson DL
J Virol; 1997 Mar; 71(3):2192-201. PubMed ID: 9032353
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma production specific for hepatitis B virus antigen by intrahepatic T lymphocytes in patients with acute and chronic hepatitis B.
Kakumu S; Ishikawa T; Wakita T; Yoshioka K; Takayanagi M; Tahara H; Kusakabe A
Am J Gastroenterol; 1994 Jan; 89(1):92-6. PubMed ID: 8273806
[TBL] [Abstract][Full Text] [Related]
10. Cellular immune responses of peripheral blood mononuclear cells to HBV antigens during chronic and acute HBV infection.
Wakita T; Kakumu S; Yoshioka K; Ishikawa T; Ito Y; Shinagawa T
Digestion; 1992; 52(1):26-33. PubMed ID: 1426694
[TBL] [Abstract][Full Text] [Related]
11. Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus.
Marinos G; Torre F; Chokshi S; Hussain M; Clarke BE; Rowlands DJ; Eddleston AL; Naoumov NV; Williams R
Hepatology; 1995 Oct; 22(4 Pt 1):1040-9. PubMed ID: 7557849
[TBL] [Abstract][Full Text] [Related]
12. Proliferative response of CD4+ T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e-minus hepatitis B virus mutants.
Löhr HF; Weber W; Schlaak J; Goergen B; Meyer zum Buschenfelde KH; Gerken G
Hepatology; 1995 Jul; 22(1):61-8. PubMed ID: 7601434
[TBL] [Abstract][Full Text] [Related]
13. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
[TBL] [Abstract][Full Text] [Related]
14. HBV-specific immune defect in chronic hepatitis B (CHB) is correlated with a dysregulation of pro- and anti-inflammatory cytokines.
Schlaak JF; Tully G; Löhr HF; Gerken G; Meyer zum Büschenfelde KH
Clin Exp Immunol; 1999 Mar; 115(3):508-14. PubMed ID: 10193426
[TBL] [Abstract][Full Text] [Related]
15. Role of hepatitis B virus in non-B, non-C chronic liver disease: in vitro proliferation and interferon-gamma production of peripheral blood mononuclear cells in response to hepatitis B core antigen and its relation to hepatitis activity.
Niigaki M; Fukuda R; Hamamoto S; Ishimura N; Ishihara S; Akagi S; Watanabe M; Kinoshita Y
Am J Gastroenterol; 2000 Jan; 95(1):239-47. PubMed ID: 10638591
[TBL] [Abstract][Full Text] [Related]
16. HBV-specific lymphoproliferative and cytokine responses in patients with chronic hepatitis B.
Vingerhoets J; Michielsen P; Vanham G; Bosmans E; Paulij W; Ramon A; Pelckmans P; Kestens L; Leroux-Roels G
J Hepatol; 1998 Jan; 28(1):8-16. PubMed ID: 9537868
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.
Rico MA; Quiroga JA; Subirá D; Castañón S; Esteban JM; Pardo M; Carreño V
Hepatology; 2001 Jan; 33(1):295-300. PubMed ID: 11124848
[TBL] [Abstract][Full Text] [Related]
18. Gamma-interferon production in response to hepatitis B core protein and its synthetic peptides in patients with chronic hepatitis B virus infection.
Wakita T; Kakumu S; Tsutsumi Y; Yoshioka K; Machida A; Mayumi M
Digestion; 1990; 47(3):149-55. PubMed ID: 1707382
[TBL] [Abstract][Full Text] [Related]
19. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin-hepatitis B core antigen-cytoplasmic transduction peptide enhances HBV-specific humoral and CTL immune responses in vivo.
Song L; Zhuo M; Tang Y; Chen X; Tang Z; Zang G
Int Immunopharmacol; 2014 Nov; 23(1):1-7. PubMed ID: 25135878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
